NEOVACS |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1599 EUR | -6.27% |
|
-6.60% | -92.00% |
| 05-29 | Neovacs: mRNA approach validated in preclinical trial | CF |
| 05-27 | Neovacs: collaboration contract with INSERM team | CF |
- Stock Market
- Equities
- ALNEV Stock
- News NEOVACS
- Analyst Reco.
